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ABSTRACT 
Cardiovascular disease is number one killer disease in the world. The most 
common etiology is atherosclerosis. LDL and HDL-cholesterol are often 
associated with atherosclerosis which are affected by diet. Quercetin and 
curcumin considered have influenced to LDL and HDL. They are antioxidant that 
protect against LDL oxidation and raised HDL-cholesterol. In this study, we 
invest about comparison effect of prevention in LDL and HDL level change, after 
giving quercetin and curcumin. 20 males Rattus novergicus rats in 200-300 grams 
divided into 4 groups. Group B, C, D were given high-fat diet for 4 weeks, while 
group A (negative control) was given standard woof. Group B was positive 
control and no treatment, C was given quercetin, D was given curcumin. The 
treatment and giving high-fat diet was done simultaneously to detect prevention 
effect. HDL and LDL-cholesterol evaluated two times, pre and post-treatment. 
Result showed the increase prevention level of LDL-cholesterol and decrease 
prevention level of HDL-cholesterol in group C and D significantly. The best 
prevention effect is quercetin, p=0.000. Furthermore, we showed there was no 
significant correlation between LDL and HDL-cholesterol level. In conclusion, 
quercetin and curcumin have a good effect in preventing hypercholesterolemia, 
however quercetin have better effect than curcumin. 
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INTRODUCTION 
Cardiovascular disease 
(CVD) is the most common cause of 
deaths worldwide, about 80% of the 
burden occurs in developing 
countries (Kumar et al., 2010).  CVD 
includes  all diseases in the heart and 
blood vessels. WHO (2008) 
estimated 17.3 million people died 
by CVD, about 7.3 million were due 
to coronary heart disease and 6.2 
million were due to stroke. 
Atherosclerosis is one of common 
causes of stroke.  
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Atherosclerosis is the most 
common pathological feature of 
vascular obstruction resulting in 
thrombotic stroke. It is characterized 
by intimal lesions called atheromas 
that protrude into vessel lumens. 
Atherosclerosis formation depends 
on lipid level in the blood. 
Hypercholesterolemia is a major risk 
factor for atherosclerosis even in the 
absence of other factors. The major 
component of serum cholesterol 
associated with increased risk of 
atherosclerosis event is low density 
lipoprotein cholesterol (LDL-C). 
LDL-C is the form of cholesterol that 
is delivered to peripheral tissues. In 
contrast, high density lipoprotein 
cholesterol (HDL-C) mobilizes 
cholesterol from tissue and transports 
it to the liver to be excreted in the 
bile. Consequently, higher levels of 
HDL-C correlate with reduced risk 
(Kumar et al., 2010). 
Atherosclerosis can be 
prevented by controlling the risk 
factors, particularly such as cigarette 
smoking, unhealthy diet, physical 
inactivity, high blood pressure, 
diabetes, and raised lipids. Lipid 
levels in the blood are affected by 
diet including additional diet, such as 
antioxidant that can reduce LDL-C 
levels and increase HDL-C levels. It 
prevents targeted molecule to be 
oxidized by free radical. According 
to the oxidative modification 
hypothesis, Wang et al. (2012) said 
oxidation of LDL is crucial to the 
cellular uptake of LDL in the first 
stage of atherosclerotic plaque 
development. Because of that reason, 
antioxidant plays vital role in 
preventing atherosclerosis.  
Curcumin and quercetin are 
antioxidants that have not been 
widely used. Curcumin has 
pharmacological effects including 
antitumor and anti-inflammation 
effects and can prevent lipid 
peroxidation. Sudjarwo (2011) 
concludes that curcumin can repair 
endothelium-dependent dilation at 
blood vessels wall and reduce lipid 
peroxidation in aorta wall. Quersetin 
is a flavonoid that can also affect 
lipid levels in the blood by reducing 
LDL-C concentrations. Flavonoids, 
particularly quercetin has been 
associated with a decreased risk of 
CVD. Quersetin can be found in 
onion, green tea, and apple. Based on 
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the effect of each compound, 
combination of both quercetin and 
curcumin are expect to be more 
effective in managing 
hypercholesterolemia and in 
preventing atherosclerosis. This 
study compares quarcetin and 
curcumin, in preventing 
hypercholesterolemia.  
 
METHOD 
Chemicals 
Quercetin and Na-CMC were 
of analytical grade obtained from 
Sigma Aldrich Chemical and the 
curcumin were procured from Doctor 
Eko Wahjuni (POM TR 023 217 
101). 
Animals 
Animal experiments were 
carried out taking appropriate 
measures to minimize pain or 
discomfort with due clearance from 
the Medical and Health Research 
Ethics Committee, Faculty of 
Medicine Universitas Gadjah Mada 
(UGM) 
Male wistar rats (Rattus 
novergicus) weighing between 200-
300 g each were used for this 
experiment. They were procured 
from PAU Laboratory UGM, 
Yogyakarta. The rats were 
maintained in a controlled 
environment under standard 
condition of temperature (28+2
o
C) 
and humidity with an alternating 
light and dark cycle. The animals 
were housed in individual stainless 
steel cages were maintained on 
various experimental diets ad 
libitum. The basal diet used was AD-
2 woof and the hypercholesterolemic 
diet consisted of AD-2 woof plus 
cow’s fat which administered by 
sonde. 
Experimental Procedure 
After a week of 
acclimatization, the rats were divided 
into four groups with 5 rats in each 
group. Group I served as negative 
control (basal diet+1 mL Na-CMC 
0.5%), Group 2 served as positive 
control (hypercholesterolemic diet+1 
mL Na-CMC 0.5%), Group 3 treated 
with hypercholesterolemic diet+ 
45mg/kgBW quercetin+1 mL Na-
CMC 0.5%, Group 4 treated with 
hypercholesterolemic diet+45 
mg/kgBW curcumin+1 mL Na-CMC 
0.5%. After 4 weeks of treatment 
period, the animals were sacrificed 
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under light ether anesthesia. Blood 
was collected by orbital artery for 
two times. First, at the end of 
acclimatization, and second at the 
end of experiment. Blood was 
separated from serum by 
sentrifugation and used for lipid 
analysis. 
Lipid Profile 
HDL and LDL-cholesterol 
were determined by homogenous 
enzymatic colorimetric assay 
method. 
Statistical Analysis 
Result are expressed as 
means+SD and comparison between 
groups were made by means of one-
way ANOVA. Comparison among 
different groups were made applying 
the Tukey Post Hoc Test and were 
considered significant when p<0.05. 
 
RESULT AND DISCUSSION 
As observed in this study, high 
cholesterol feeding for 4 weeks 
resulted in a significant increase in 
LDL-cholesterol concentration and a 
decrease in HDL-cholesterol (Table 
1 and 2). The increased in LDL-
cholesterol and decreased in HDL-
cholesterol were variously. Dietary 
quercetin or curcumin prevented the 
increase of LDL-cholesterol 
significantly. However, quercetin 
prevented better than curcumin. 
 
Table I. Effect of quercetin and curcumin in 
HDL-cholesterol 
 
HDL-cholesterol essentially 
decrease in all group significantly. 
Quercetin was prevented the 
decrease of HDL-cholesterol 
significantly in compared to control. 
As shown in Table 3, there was 
no significant correlation between 
increased in LDL-cholesterol with 
decreased in HDL-cholesterol. Data 
shows that quercetin or curcumin 
treated group had a very weak 
positive correlation. It means the 
increased in LDL-cholesterol make 
HDL-cholesterol slightly increased.  
 HDL-
cholesterol 
(mg/dL)  
Pre-
test 
Post-
test 
Normal 38.92
+1.93 
38.44
+1.63 
-0.48 
+2.59 
Control 37.17
+1.93 
16.82
+1.83 
-20.35 
+1.50 
Quercetin 36.09
+1.40 
30.95
+1.83 
-5.14 
+2.37* 
Curcumin 36.9 
+1.11 
17.38
+1.70 
-19.51 
+1.36
#
 
Tested by Tukey Post Hoc Test;  
*Significantly different from control (p < 
0.05) 
#
p>0.05 
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Table II. Effect of quercetin and curcumin in LDL-cholesterol 
 
 
 
 
 
 
 
 
 
 
 
 
Table III. Correlation between increased in LDL and decreased in HDL-cholesterol 
 r p 
Normal -0.864 0.059 
Control -0.146 0.815 
Quercetin 0.219 0.723 
Curcumin 0.123 0.843 
Tested by Pearson Correlation; 
Significantly different if p<0.05 
 
Epidemiological studies have 
reported a reduced risk of coronary 
heart disease in subjects with high 
flavonoid intake (Knekt et al., 1995). 
The protective effect of flavonoids 
has been attributed to many 
mechanisms, i.e. antioxidant 
properties, anti-inflammatory activity 
(Miller A, 1996), antiproliferative as 
well as antipatelet effects 
(Moghaddam et al., 2012; Guerrero 
et al., 2005). 
In the present study, hypo-
lipidemic effects was evaluated in 
two substance. It was demonstrated 
that all treatment groups showed a 
positive effect in the prevention of 
hyper-cholesterolemia, which 
prevents the increase in LDL as well 
as prevent a significant decrease in 
HDL (Table I and II). 
These results are consistent 
with the theory presented by 
Srinivasan et al. (2004) which states 
that curcumin has hypolipidemic 
activity, by increasing receptor LXR 
(liver X receptor) and RXR (retinoic 
X receptor), which causes an 
increase in metabolism of 
cholesterol, especially LDL uptake 
increase. Although it has an excellent 
effect on hypolipidemic, the major 
 LDL-cholesterol (mg/dL) 
 
Pre-test Post-test 
Normal 50.16+2.38 53.11 +2.35 2.94 +0.36 
Control 45.02+2.31 89.76 +2.52 44.75 +3.42 
Quercetin 48.84+6.28 63.54 +2.99 14.7 +8.99* 
Curcumin 44.35+7.47 78.39 +1.73 34.04 +8.36* 
Tested by Tukey Post Hoc Test;  
*Significantly different from control (p < 0.05) 
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concern of curcumin is a limited 
bioavailability which limits its 
therapeutic utility (Anand et al. 
2007). 
Earlier studies have shown that 
quercetin significantly inhibit in vitro 
LDL oxidation, and also protects 
macrophages from oxidized low-
density lipoprotein induced apoptosis 
(Naderi et al., 2003; Yao et al., 
2012). Quercetin acts to inhibit 
atherosclerosis through up-regulation 
of reverse cholesterol transport, so as 
to reduce cholesterol levels in the 
blood (Fernandes et al., 2012). 
Quercetin inhibits sulfotransferase 
enzymes and also limited by poor 
bioavailability though it’s better than 
curcumin (Kaur G & Meena C, 
2012). 
The mechanisms of each 
compounds lead to the prevention 
effects of hypercholesterolemia. 
However, based on this study, 
quercetin was more impressive 
effect. Quercetin was effective in 
prevent hypercholesterolemia by 
high-fat diet, after 4-weeks of the 
experiment. While this activity was 
less prominent in the curcumin 
treatment.  
It is well known that HDL-
cholesterol levels have a protective 
role in cardiovascular disease 
(Silbernagel et al., 2013). Similarly 
increased level of LDL-cholesterol 
results in increased risk of 
development of atherosclerosis 
(Warnholtz et al., 2001). However, 
the study exhibited that there was no 
significant correlation between 
increases in LDL-cholesterol with 
decreases in HDL-cholesterol.  
The anti-atherogenic properties 
were described to the antioxidant 
activity measured by the reduced 
formation of LDL-cholesterol and 
enhaced formation of HDL-
cholesterol. Quercetin in dose 
45mg/kgBW prevented hyper-
cholesterolemia optimal, although it 
had not reached normal conditions. 
 
CONCLUSION 
The quercetin in 45mg/kgBW 
dose is the best treatment in this 
study, because the maximum 
preventive effect. Preventive effects 
of hypercholesterolemia slowing the 
formation of fatty streak which is 
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going from atherosclerosis, the 
biggest risk factor for cardiovascular 
diseases. 
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